Factors associated to loss of follow-up in patients underwent antiretroviral therapy in an ambulatory HIV treatment center at Conakry

被引:2
作者
Toure, A. [1 ]
Cisse, D. [1 ]
Kadio, K. J. J. O. [1 ]
Camara, A. [1 ]
Traore, F. A. [2 ]
Delamou, A. [1 ]
Sidide, S. [1 ]
Kouyate, C. [3 ]
Bangoura, I. S. [3 ]
Diallo, M. M. [4 ]
Tounkara, T. M. [5 ]
Traore, F. [6 ]
Sow, M. S. [2 ]
Khanafer, N. [7 ]
Cisse, M. [5 ]
机构
[1] Univ Gamal Abdel Nasser Conakryf, Fac Med Pharm Odonto Stomatol, Chaire Sante Publ, BP 1017, Conakry, Guinea
[2] Hop Natl Donka, Serv Malad Infect & Trop, Conakry, Guinea
[3] Assoc Femmes Guinee Lutte IST & Sida ASFEGMASSI, Conakry, Guinea
[4] Solidarite Therapeut & Initiat Sante Solthis, Conakry, Guinea
[5] Hop Natl Donka, Serv Dermatol Venerol MST, Conakry, Guinea
[6] Inst Natl Sante Publ, Conakry, Guinea
[7] Hosp Civils Lyon, Hop Edouard Herriot, Epidemiol & Infect Control Unit, F-69003 Lyon, France
来源
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE | 2018年 / 66卷 / 04期
关键词
HIV; HAART; Loss to follow-up; Guinea; INFECTED PATIENTS; OUTCOMES; SURVIVAL; ETHIOPIA; AFRICA; CARE;
D O I
10.1016/j.respe.2018.04.057
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. - Late or inadequate therapeutic management increases the risk of mortality associated with HIV/AIDS. The aim of this study was to analyze the proportion and factors associated with loss of follow-up in HIV patients who receiving antiretroviral therapy at Conakry. Methods. - A retrospective cohort study was conducted in HIV patients aged over 15 years and who receiving antiretroviral therapy. Between August 1, 2008 and July 31, 2015, all patients managed by the ambulatory treatment center of the Guinean Women Association against AIDS and sexually and transmissible infection were included. Loss of follow-up was defined as no follow-up visit within 3 months. Kaplan-Meier curves and multivariate Cox regression models were used to analyze factors associated with loss of follow-up. Analyses were performed by using Stata 13 software. Results. - 614 patients aged 36.3 +/- 11.2 years, mainly females (68.4%) and living in Conakry (80.5%) were included. Among them, 104 were loss to follow-up, corresponding to a proportion rate of 16.9% (95% CI: 14.2-19.7%) or 5.79/100 person-years. The results of multivariate analyses showed that factors independently associated with loss of follow-up were malnutrition (AHR = 7.05; 95% CI: 2.05-24.27; P = 0.002) and CD4 cells account at the initiation of AHR (2.35; 95% CI: 1.61-6.39; P = 0.016) in patients with 201-350 CD4/mu L and 5.83 (95% CI: 2.85-11.90; P < 0.001) in patients with less than 150 CD4/mu L. Conclusion. - Despite efforts of health care workers and free antiretroviral therapy, many patients were loss to follow-up. Multivariate analysis showed that malnutrition and low CD4 account were independently associated with loss to follow-up. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:273 / 279
页数:7
相关论文
共 50 条
  • [31] Risk factors for loss to follow-up from antiretroviral therapy programmes in low-income and middle-income countries
    Frijters, Elise M.
    Hermans, Lucas E.
    Wensing, Annemarie M. J.
    Deville, Walter L. J. M.
    Tempelman, Hugo A.
    De Wit, John B. F.
    AIDS, 2020, 34 (09) : 1261 - 1288
  • [32] Loss to follow-up and mortality among HIV-infected adolescents receiving antiretroviral therapy in Pune, India
    Nimkar, S.
    Valvi, C.
    Kadam, D.
    Rewari, B. B.
    Kinikar, A.
    Gupte, N.
    Suryavanshi, N.
    Deluca, A.
    Shankar, A.
    Golub, J.
    Bollinger, R.
    Gupta, A.
    Marbaniang, I.
    Mave, V.
    HIV MEDICINE, 2018, 19 (06) : 395 - 402
  • [33] Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015)
    Mutanga, Jane N.
    Mutembo, Simon
    Ezeamama, Amara E.
    Song, Xiao
    Fubisha, Robert C.
    Mutesu-Kapembwa, Kunda
    Sialondwe, Derrick
    Simuchembu, Brenda
    Chinyonga, Jelita
    Thuma, Philip E.
    Whalen, Christopher C.
    BMC PUBLIC HEALTH, 2019, 19 (01)
  • [34] Incidence and predictors of loss to follow-up among adult HIV patients attending antiretroviral therapy at public health facilities in Agaro town, Southwest Ethiopia, 2023
    Ahmed, Abduljebar Mohammed
    Sisay, Assefa Legesse
    Gebre, Mamo Nigatu
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [35] Loss to follow-up of patients in HIV care in Burundi: A retrospective cohort study
    Nshimirimana, Clement
    Ndayizeye, Aime
    Smekens, Tom
    Vuylsteke, Bea
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2022, 27 (06) : 574 - 582
  • [36] Operational research and HIV policy and guidelines: Lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon
    Mben, Jean-Marc
    Kouanfack, Charles
    Essomba, Claudine Ntsama
    Mbougua, Jules Brice Tchatchueng
    Kenfack, Alain
    Tonfack, Clement Auguste Djouatsa
    Laborde-Balen, Gabriele
    Bourgeois, Anke
    Biwole-Sida, Magloire
    Delaporte, Eric
    Laurent, Christian
    JOURNAL OF PUBLIC HEALTH POLICY, 2012, 33 (04) : 462 - 477
  • [37] High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa
    Chandiwana, Nomathemba
    Sawry, Shobna
    Chersich, Matthew
    Kachingwe, Elizabeth
    Makhathini, Bulelani
    Fairlie, Lee
    MEDICINE, 2018, 97 (29)
  • [38] Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya
    Ojwang', V. O.
    Penner, J.
    Blat, C.
    Agot, K.
    Bukusi, E. A.
    Cohen, C. R.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2016, 28 (04): : 500 - 507
  • [39] Factors associated with virologic failure in HIV patients on antiretroviral therapy
    Gomez, Carlos
    Madrigal-Cadavid, Juliana
    Andres Giraldo, Paulo
    Miguel Abad, Jose
    Alberto Serna, Juan
    Segura, Angela
    Ivan Estrada-Acevedo, Jorge
    FARMACIA HOSPITALARIA, 2022, : 282 - 289
  • [40] Dual Analysis of Loss to Follow-up for Perinatally HIV-Infected Adolescents Receiving Combination Antiretroviral Therapy in Asia
    Bartlett, Adam W.
    Lumbiganon, Pagakrong
    Mohamed, Thahira A. Jamal
    Lapphra, Keswadee
    Muktiarti, Dina
    Quy Tuan Du
    Hansudewechakul, Rawiwan
    Ly, Penh Sun
    Khanh Huu Truong
    Lam Van Nguyen
    Puthanakit, Thanyawee
    Sudjaritruk, Tavitiya
    Chokephaibulkit, Kulkanya
    Do, Viet Chau
    Kumarasamy, Nagalingeswaran
    Yusoff, Nik Khairulddin Nik
    Kurniati, Nia
    Fong, Moy Siew
    Wati, Dewi Kumara
    Nallusamy, Revathy
    Sohn, Annette H.
    Kariminia, Azar
    Khol, V.
    Tucker, J.
    Ezhilarasi, C.
    Kinikar, A.
    Mave, V.
    Nimkar, S.
    Vedaswari, D.
    Ramajaya, I. B.
    Fong, S. M.
    Lim, M.
    Daut, F.
    Mohamad, P.
    Mohamed, T. J.
    Drawis, M. R.
    Chan, K. C.
    Sirisanthana, V.
    Aurpibul, L.
    Ounchanum, P.
    Denjanta, S.
    Kongphonoi, A.
    Kosalaraksa, P.
    Tharnprisan, P.
    Udomphanit, T.
    Jourdain, G.
    Anugulruengkit, S.
    Jantarabenjakul, W.
    Nadsasarn, R.
    Phongsamart, W.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 82 (05) : 431 - 438